2020
DOI: 10.22159/ijpps.2020v12i10.39193
|View full text |Cite
|
Sign up to set email alerts
|

The Potential Modulatory Effect of Rutin on Titanium Dioxide Nanoparticles-Induced Renal Injury in Male Mice

Abstract: Objective: This study aimed to investigate the possible protective effect of rutin in management of TiO2NPs-induced renal injury in mice. Methods: Forty male Swiss albino mice were randomly divided into four groups (n=10). Group (I) served as a control group, group (II) received 100 mg/kg body weight (b. wt) of rutin (orally), group (III) received 70 mg/kg b. wt of TiO2NPs,injected intraperitoneally (i. p.), Group (IV) received 70 mg/kg b. wt of TiO2NPs plus 100 mg/kg b. wt of rutin; for 14 successive da… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 39 publications
(51 reference statements)
0
1
0
Order By: Relevance
“…The toxic nature of present anticancer drugs has led to a search for novel drugs that are selectively toxic to cancer cells [16]. There is a marked increase in the number of anticancer drugs of plant origin as they are found to be potentially non-toxic [17,18], which are tested on cells (including various cancer cell lines) [19] and experimental animals after purification and then sent to clinical trials [20]. From 2006 to 2014, there was a significant increase in the number of newly discovered anticancer molecules from 50,000 to 3,26,000, among which 1,76,000 failed to show selective toxicity [21].…”
Section: Discussionmentioning
confidence: 99%
“…The toxic nature of present anticancer drugs has led to a search for novel drugs that are selectively toxic to cancer cells [16]. There is a marked increase in the number of anticancer drugs of plant origin as they are found to be potentially non-toxic [17,18], which are tested on cells (including various cancer cell lines) [19] and experimental animals after purification and then sent to clinical trials [20]. From 2006 to 2014, there was a significant increase in the number of newly discovered anticancer molecules from 50,000 to 3,26,000, among which 1,76,000 failed to show selective toxicity [21].…”
Section: Discussionmentioning
confidence: 99%